TNF Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets

Intangible Assets

9 Months Ended

Sep. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Note 7 - Intangible Assets

Intangible assets as of September 30, 2016 and December 31, 2015 and the movements for the three months then ended are as follows:

			Distributor &
	Patents &		Customer
	Trademarks		Relationships		Totals
*Cost or Deemed Cost*
At December 31, 2015	$	2,626,996	$	1,270,639	$	3,897,635
Additions		-		-		-
Disposals		-		-		-
At September 30, 2016	$	2,626,996	$	1,270,639	$	3,897,635

*Accumulated Amortization*
At December 31, 2015	$	1,154,113	$	1,270,639	$	2,424,752
Amortization Charge		128,331		-		128,331
Disposals		-		-		-
At September 30, 2016	$	1,282,444	$	1,270,639	$	2,553,083

*Net Book Value*
At December 31, 2015	$	1,472,883	$	-	$	1,472,883
At September 30, 2016	$	1,344,552	$	-	$	1,344,552

Amortization expense was $42,777 and $128,331 for the three and nine months ended September 30, 2016 and $64,643 and $193,929 for the three and nine months ended September 30, 2015.

Impairment expense was $- for the three and nine months ended September 30, 2016 and $466,476 for the three and nine months ended September 30, 2015.